Lovell Stephanie
SEC Form 4 insider trading activity
Lovell Stephanie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.
On the most recent filing, Lovell Stephanie is listed as Director at TransMedics Group, Inc. Inside the rolling window, Lovell Stephanie reported no open-market purchases and 1 open-market sale totaling $178K in TMDX.
Companies traded
Other insiders at TMDX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$178K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lovell Stephanie made?
Lovell Stephanie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Lovell Stephanie trade?
Lovell Stephanie has filed SEC Form 4 disclosures for 1 company, including TMDX.
When was Lovell Stephanie's most recent SEC Form 4 filing?
Lovell Stephanie's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.
What is Lovell Stephanie's total buy and sell value in the current window?
Inside the rolling retention window, Lovell Stephanie bought $0 and sold $178K based on SEC Form 4 filings.
What was Lovell Stephanie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,193 TMDX shares on 2026-03-04, worth $178K, per SEC Form 4 filings.